YDES

YD Bio Ltd

Aug 29 • 04:00PM ET

12.50

Dollar change +7.20
Percentage change 135.85	%

Healthcare • Biotechnology • USA • NASD

Index	-	P/E	-	EPS (ttm)	-0.99	Insider Own	-	Shs Outstand	3.36M	Perf Week	-
Market Cap	41.44M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	0.78M	Perf Month	-
Enterprise Value	41.43M	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-2.97M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	0.00M	P/B	-	EPS next Y	-	ROA	-43.61%	Short Interest	-	Perf YTD	-
Book/sh	-4.77	P/C	4143.87	EPS next 5Y	-	ROE	-	52W High	- -	Perf Year	-
Cash/sh	0.00	P/FCF	-	EPS past 3/5Y	- -33.79%	ROIC	-	52W Low	- -	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	- -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	9.30	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.02	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.02	EPS Q/Q	-116.03%	SMA20	0.00%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	0.00%	Rel Volume	-	Prev Close	5.30
Employees	4	LT Debt/Eq	-	Earnings	-	SMA200	0.00%	Avg Volume	-	Price	12.50
IPO	-	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	904,747	Change	135.85%

Today 07:30AM

YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market

(PR Newswire)

Breeze Holdings Acquisition Corp. is a blank check company, which engages in the business of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on June 11, 2020 and is headquartered in Irving, TX.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

YDES

YD Bio Ltd

Upgrade your FINVIZ experience